Cross sectional study to investigate the difference in needs between patients and health care providers for systemic therapy of renal cell carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1040220016

Enrollment

Registered

2022-05-03

Start date

2022-05-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal cell carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Agreed web questionnaire survey. - 20 year and older. - Live in Japan. - Received or ongoing molecular targeted therapy or immune checkpoint inhibitor (including combination therapy) for renal cell carcinoma. - Agreed web questionnaire survey. - Doctors, nurses, or pharmacists who are engaged in systemic therapy of renal cell carcinoma.

Exclusion criteria

Exclusion criteria: - Have families engaged in pharmatheutical/survey/marketing company or health care. - Have double cancer. - Doctors, nurses, or pharmacists who are not engaged in systemic therapy of renal cell carcinoma.

Design outcomes

Primary

Measure	Time frame
Difference in preferences of systemic therapy between patients and doctors.	—

Secondary

Measure	Time frame
- Difference in preferences of systemic therapy between patients and nurses or pharmacists. - Health care providers who have the most similar preferences of systemic therapy to patients. - The most painful adverse events for patients. - Adverse events which patients are reluctant to tell health care providers. - Difference in recognitions of adverse events between patients and health care providers. - Adverse events which need intervention of nurses or pharmacists. - The most difficult adverse events to manage for health care providers. - Difference in recognitions of adverse events which need intervention of nurses or pharmacists between doctors, nurses, and pharmacists. - Recognition of health care providers for employment status of patients. - Recognition of health care providers for cost of systemic therapy.	—

Measure

Time frame

- Difference in preferences of systemic therapy between patients and nurses or pharmacists. - Health care providers who have the most similar preferences of systemic therapy to patients. - The most painful adverse events for patients. - Adverse events which patients are reluctant to tell health care providers. - Difference in recognitions of adverse events between patients and health care providers. - Adverse events which need intervention of nurses or pharmacists. - The most difficult adverse events to manage for health care providers. - Difference in recognitions of adverse events which need intervention of nurses or pharmacists between doctors, nurses, and pharmacists. - Recognition of health care providers for employment status of patients. - Recognition of health care providers for cost of systemic therapy.

—

Contacts

Public ContactMitsuda Yoshihide

Eisai Co., Ltd.

y2-mitsuda@hhc.eisai.co.jp+81-70-4560-7293

Outcome results